Zydus Cadila's Q3 PBT dips 32% to Rs 457 cr, revenue up marginally

Formulation sales in US up 16% sequentially to Rs 1,675 cr, rest-of-the-world biz consisting of multiple emerging markets grew by 21%

Cadila Healthcare Ltd. (Zydus Cadila) has reported a consolidated profit before tax (PBT) of Rs 457.1 crore, down by 31.94 per cent for the third quarter ended December 31, 2019 on a year-on-year (YoY) basis, based on its filing with exchanges on Wednesday.

The company's consolidated PBT for Q3 of previous fiscal 2018-19 stood at Rs 671.7 crore. Zydus Cadila posted a marginal 1.3 per cent rise in its total revenue for Q3 of FY20, at Rs 3,658.2, crore, from Rs 3,608.9 crore for the corresponding period last year. 

On Wednesday, Zydus Cadila stated that its formulations business in the US posted